ETFs Zoetis Inc.

ZTS

US98978V1035

Name	Varia. Jan 1.	Weight	AuM
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+0.75%	3.35%	26 M€
FIRST TRUST INDXX INNOVATIVE TRANSACTION AND PROCESS ETF - CAD	0.00%	1.35%	1 M€
HAMILTON ENHANCED MULTI-SECTOR COVERED CALL ETF - CAD	+4.48%	0.77%	711 M€
HAMILTON ENHANCED U.S. COVERED CALL ETF - CAD HEDGED	+0.88%	0.65%	598 M€
HAMILTON ENHANCED U.S. COVERED CALL ETF - USD	+1.08%	0.65%	69 M€
LYXOR MSCI USA ESG BROAD CTB (DR) UCITS ETF - DIST - EUR	-.--%	0.52%	1,006 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.00%	0.4%	2 M€

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.

Employees

13,800

Sector

Pharmaceuticals

Calendar

02-12 - Q4 2025 Earnings Release

More about the company